iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.

Fabricantes de medicamentos genéricos y especializados

Mr. Robert R. Galvin

Interim Chief Executive Officer & Chief Operating Officer

Mr. Richie  Proud

Chief Executive Officer & Director

Interim Chief Operating Officer

Mr. Philippe  Faraut

Chief Financial Officer

Mr. Richard  Proud

Ms. Megan W. Kulick CFA

Vice President of Investor Relations

Mr. Andrew R. Ryan Esq.

Gen. Counsel

Mr. Michael R. Woolston

Senior Vice President of Manufacturing, Supply Chain & Quality

Nombre	Capitalización
China Medical System Holdings Limited	0M
CanSino Biologics Inc.	0M
ZIM Laboratories Limited	0M
Indoco Remedies Limited	0M
Bod Science Limited	0M
Aion Therapeutic Inc.	0M
Canzon Israel Ltd	0M
Lincoln Pharmaceuticals Limited	0M
SCYNEXIS, Inc.	0M

iAnthus Capital Holdings, Inc.

iAnthus Capital Holdings, Inc. Lista de competidores

Principales competidores